Opioid & Steroid Use Following Tonsillectomy in Pediatric Patients
Launched by DUKE UNIVERSITY · Sep 1, 2020
Trial Information
Current as of May 04, 2025
Terminated
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 4-17 years at time of surgery
- • Scheduled for tonsillectomy or adenotonsillectomy surgery
- Exclusion Criteria:
- • Prior history of intracapsular tonsillectomy
- • Previous diagnoses of Down Syndrome or developmental delay
- • Presence of gastrostomy (g) tube
- • A contraindication to steroids or steroid usage within 30 days prior to surgery including diabetes, allergy to steroid, already on chronic steroid, immune deficiency
- • Active infection or concurrent operative procedures at the time of surgery
- • Unable to read or speak English
- • Pregnant or breastfeeding females
About Duke University
Duke University, a leading academic and research institution located in Durham, North Carolina, is renowned for its commitment to advancing healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, Duke conducts a wide array of clinical trials aimed at developing cutting-edge therapies and improving patient outcomes across various medical fields. The university's Clinical Research Institute provides comprehensive support for trial design, implementation, and regulatory compliance, ensuring that all research adheres to the highest ethical and scientific standards. Duke’s dedication to translating research findings into effective clinical practices underscores its role as a pivotal contributor to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Durham, North Carolina, United States
Patients applied
Trial Officials
Eileen Raynor, MD
Principal Investigator
Duke Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials